Saliva

• TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today a corporate update on the research, clinical and regulatory initiatives with Bucillamine and its long COVID diagnostic product.
• Exposure to nerve agents can cause tightness of the chest, excessive salivation, abdominal cramps, diarrhea, blurred vision, tremors, and death.
• In addition, Revive may evaluate the potential of its proposed long COVID diagnostic product as a companion to Bucillamine.
• The Company, under its wholly-owned subsidiary Revive Diagnostics Inc., is advancing the product development of a potential blood biomarker diagnostic that characterizes long COVID.

• "We are delighted to bring the experience and expertise of Broad Clinical Labs to this innovative collaboration with Quest.
• "This type of collaboration between commercial laboratories and research institutions is vital to advance the field of genetic testing and increase utility and economic value."
• While the ACMG recommends WGS for first-line genetic testing for intellectual disability and developmental delay, some providers continue to follow prior guidelines that recommend chromosomal microarray (CMA) as a first-line test.
• Broad Clinical Labs is a leader in human whole genome sequencing, having sequenced over 600,000 genomes in service of its mission to accelerate the understanding and diagnosis of human disease.

• An experimental study, released today, looks into whether apple cider vinegar could be effective for weight loss, reduce blood glucose levels and reduce blood lipids (cholesterol and triglycerides).
• The results suggest it could reduce all three – but it might not be as simple as downing an apple cider vinegar drink a day.

What did they do?

• A control group consumed an inactive drink (a placebo) made (from lactic acid added to water) to look and taste the same.
• The study was also double-blinded, which means neither the participants or the scientists involved with collecting the data knew who was in which group.

So, what did they find?

• After a period of three months apple cider vinegar consumption was linked with significant falls in body weight and body mass index (BMI).
• On average, those who drank apple cider vinegar during that period lost 6–8kg in weight and reduced their BMI by 2.7–3 points, depending on the dose.
• The authors also report significant decreases in levels of blood glucose, triglycerides, and cholesterol in the apple cider groups.

Is this good news?

• Firstly, study participants were aged from 12 to 25, so we can’t say whether the results could apply to everyone.
• And while the researchers kept records of the participants’ diet and exercise during the study, these were not published in the paper.
• This could be important and influence results if people who did not lose weight quit due to lack of motivation.

Read more:
Turns out the viral 'Sleepy Girl Mocktail' is backed by science. Should you try it?

Any other concerns?

Apple cider vinegar is acidic and there are concerns it may erode tooth enamel. This can be a problem with any acidic beverages, including fizzy drinks, lemon water and orange juice. To minimise the risk of acid erosion some dentists recommend the following after drinking acidic drinks:

Read more:
Apple cider vinegar: is drinking this popular home remedy bad for your teeth? A dentist explains

Down the hatch?

• This study provides us with some evidence of a link between apple cider vinegar and weight loss.
• This would provide more robust evidence that apple cider vinegar could be a useful aid for weight loss.

Evangeline Mantzioris is affiliated with Alliance for Research in Nutrition, Exercise and Activity (ARENA) at the University of South Australia. Evangeline Mantzioris has received funding from the National Health and Medical Research Council, and has been appointed to the National Health and Medical Research Council Dietary Guideline Expert Committee.

• Drug of Abuse Testing Market size is expected to hit US$ 10.28 Billion by 2030 from US$ 6.18 Billion in 2023.
• Innovations in technology are continuously emerging to expedite and enhance drug testing efficiency in response to the growing demand for such services.
• The drug abuse testing market is generally pushed by strict laws that mandate drug abuse testing, growing government initiatives concerning drug abuse, rising consumption of alcohol and different drugs, and growing mortality because of drugs.
• The growing global population engaged in alcohol and illicit drug use, encompassing substances like marijuana and cocaine, drives the drug abuse testing market's growth.